Pieter Van Vlierberghe

Professor @UGent

[Charles de Bock @charles_debock]

Visiting Leuven and lab of @CoolsJn is always inspirational. Learning about the amazing work with @Ammarilys Sofie Demeyer @QThillo @AlexandraBVelo1 and the team

[Ruud Delwel @DelwelRuud]

Our Erasmus Virtual Hematology Lectures will continue on September 19 at 16.00 CET (every two weeks) with a fantastic line up.
https://t.co/GKudvPGUSw
ID: 896 3513 0792
We will start with Omar Abdel Wahab from MSKCC.
Spread the news 📯📯
@AbdelWahablab @intercept_mds

[REMEDi4ALL @REMEDi4ALL]

By unlocking the untapped potential of existing medicines in new areas, the #REMEDI4ALL consortium will contribute, together with renowned international collaborators, to address unmet medical needs.

➡️ Find out more here: https://t.co/Bj1Q65vrov #R4ALL #MedicinesRepurposing

[Anticancer Fund @Anticancerfund]

The Anticancer Fund is very enthusiastic about this ambitious initiative in #drugrepurposing, or finding new therapeutic options for existing drugs. We have been a leader in this field to find new #cancer treatments and will now join efforts with 24 organisations! #anticancerfund

[Marlies Vanden Bempt @marlies_vdbempt]

My first postdoc paper is now online 🥳
EZH2 cooperates with MYCN in driving T cell lymphoma - as a transcriptional activator, independent of its role as a repressor in the PRC2 complex!

👇https://t.co/5dUFjc6dVI 👇

@vib_ccb @Onco_KULeuven @VIBLifeSciences @BloodJournal

[National Brain Tumor Society @NBTStweets]

Help shine a light on #GBMDay by sharing one or more of these quick, impactful stats about glioblastoma and inspire others to take action. Your voice will help highlight the need to ensure better treatments, a better quality of life, and cures for GBM patients and caregivers.

[Kaat Durinck @kdurinck]

Excited to share our latest publication
"RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition", opening perspectives for new therapeutic approaches for high-risk neuroblastoma patients.
https://t.co/OVLzMbryjR

[Kazia Therapeutics @KaziaTx]

Today is Glioblastoma Awareness Day and @KaziaTx has joined @NBTStweets to shine a light on the disease! GBM is the most treatment-resistant and deadliest brain cancer. For more info on #GBMDay and an update on $KZIA's potential #treatment, visit https://t.co/tufioQcyzk

[Trends in Immunology @TrendsImmuno]

Splicing dysregulation in human hematologic malignancies: beyond splicing mutations https://t.co/JHgAOvB4ct #immunology

[Igor Fijałkowski @igfijalkowski]

Read our review on how, other than via coding sequence mutations, splicing aberrations can cause blood cancers. We review how the scientific community targets these mechanisms for new generation of therapeutics.

[National Brain Tumor Society @NBTStweets]

Tomorrow is #GBMDay. We will not stop until we conquer and cure glioblastoma (#GBM) — once and for all. Take action now: https://t.co/r52Qian19r

[Pieter Van Vlierberghe @pvvlab]

Visiting Antwerp with my great friend and mentor ⁦@adolfo_ferrando⁩ 👍 Thanks so much for taking the time to stop ☺️ it was amazing 🤩

[Katleen De Preter @kdpreter]

Spread the word: still 2 weeks to apply for an interesting post-doc (bioIT) position in our TOBI team #ERC_COG @ugent_fge @crighent
https://t.co/45G8tyJ96o

[Speleman Lab @SpelemanLab]

Excited to share our latest publication "RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition" https://t.co/sHEkGH1RAP @crighent

[Blood Cancer Discovery @BCD_AACR]

PU.1-dependent enhancer inhibition separates Tet2-deficient #hematopoiesis from malignant transformation, by @aivaliotim et al.
https://t.co/ILEuektiGl
@EinsteinMed

[JCI insight @JCI_insight]

MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus: https://t.co/gtECPrcmrY
@JulesMeijerink @prinsesmaximac
#Hematology #Oncology

[Jennifer Trowbridge @TrowbridgeLab]

Recent grant funding successes 🎉 = time for recruiting. Join our team! For those considering postdoctoral training and interested in the biology of aging, please get in touch!

[Jean-Ehrland Ricci @jer_06200]

🤩Online today @ScienceAdvances our new study on the role of ASNS in cancer and why it cannot predict response to L-asparaginase thanks to @ChicheJohanna @MGrimaReyes and to @laliguecancer @meta_canproject for their support! https://t.co/IC3IpyzEJO

[NEXT_LEVEL Project @nextlevelEU]

Finally first research paper on #Multiomics on T-ALL biology supported and funded from the #H2020 #Twinning @nextlevelEU project! It's #openaccess so you are invited to read! https://t.co/Vz9KqLGASy
@ugent @crighent @researchumcg @uni_ulm

[Monika Pieniawska @MonPieniawska]

It was a pleasure to share my work "Epigenetic regulator HDAC10 is localized mainly in the cytoplasm and its overexpression affects the apoptosis progression in cutaneous T-cell lymphoma cells" at the 6th Polish Congress of Genetics in Cracow 🧬 @igcpan #genetics